can i mix semaglutide and tirzepatide Together for Weight Loss Switching From Tirzepatide to Semaglutide:

Retatrutide is a new type of injectable weight loss drug known as a triple hormone receptor agonist

Additional genome-wide association analysis involving 61,488 coronary artery disease patients and 163,728 controls found that the variant at rs10305492 in GLP1R is significantly associated with reduced risk of coronary artery disease, independent of the effect on reduced fasting glucose

However, using GLP-1 agonists for minor weight loss or body sculpting when one is already at a healthy weight is not only medically inappropriate but also carries significant health risks without the offsetting medical benefits

Pharmaceutics 14(4):803